COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA

被引：1
|
作者：
Whillans, F. [1 ]
Kwan, H. [1 ]
Strutton, D. R. [2 ]
Earnshaw, S. R. [3 ]
Farkouh, R. [3 ]
机构：
[1] Wyeth Pharmaceut, Markham, ON, Canada
[2] Wyeth Res, Collegeville, PA USA
[3] RTI Hlth Solut, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75101-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A425 / A425
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland
    Blank, Patricia R.
    Szucs, Thomas D.
    VACCINE, 2012, 30 (28) : 4267 - 4275
  • [32] COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN THE CZECH NATIONAL IMMUNIZATION PROGRAM
    Tichopad, A.
    Vitova, V.
    Roberts, C. S.
    Hajek, P.
    VALUE IN HEALTH, 2013, 16 (07) : A352 - A353
  • [33] Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults
    Gaillat, J.
    MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (06): : 215 - 221
  • [34] Economic evaluation of universal 7-valent pneumococcal conjugate vaccination in Taiwan: A cost-effectiveness analysis
    Wu, David Bin Chia
    Rinaldi, Fiona
    Huang, Yu Chering
    Chang, Jeffrey Andrew
    Chang, Chee Jen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (03) : 151 - 160
  • [35] EVALUATION OF HEALTH OUTCOMES AND COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION FOR INFANTS IN KAZAKHSTAN
    Bektur, C. R.
    Nurgozhin, T. S.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E76 - E76
  • [36] Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Yeh, Sylvia H.
    London, Arnold
    Sidhu, Mohinder S.
    Patterson, Scott
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1086 - 1091
  • [37] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease Reply
    Naucler, Pontus
    Galanis, Ilias
    Morfeldt, Eva
    Darenberg, Jessica
    Ortqvist, Ake
    Henriques-Normark, Birgitta
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1642 - 1643
  • [38] Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context
    Bolanos-Diaz, Rafael
    Mino-Leon, Greta
    Zea, Eduardo
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2022, 13 (04) : 341 - 350
  • [39] Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia
    Urbancikova, Ingrid
    Prymula, Roman
    Goldblatt, David
    Roalfe, Lucy
    Prymulova, Karolina
    Kosina, Pavel
    VACCINE, 2017, 35 (38) : 5186 - 5193
  • [40] THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES
    Furnback, W.
    Wang, B. C. M.
    Zhu, S.
    Dong, P.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
12345